Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Guerrero

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
International Journal of Molecular Sciences|February 15, 2022
Nanocarrier-Based Delivery of SN22 as a Tocopheryl Oxamate Prodrug Achieves Rapid Tumor Regression and Extends Survival in High-Risk Neuroblastoma ModelsIvan S Alferiev, David T Guerrero, Danielle Soberman, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 22, 2022
Poloxamer-linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high-risk neuroblastoma with primary and acquired chemoresistanceIvan S Alferiev, David T Guerrero, Peng Guan, et al.
Facial Plastic Surgery & Aesthetic Medicine|November 3, 2022
Comparison of Soluble and Liposome Encapsulated, Sustained Release Latanoprost for Focal Adipose ReductionShawn Loder, Joseph Sukinik, Matthew Cannon, et al.
Cancer Research|August 26, 2020
Structural Optimization and Enhanced Prodrug-Mediated Delivery Overcomes Camptothecin Resistance in High-Risk Solid TumorsFerro Nguyen, Peng Guan, David T Guerrero, et al.
JAMA Otolaryngology-- Head & Neck Surgery|December 5, 2024
Hypothermia During Microsurgical Head and Neck Reconstruction and Incidence of Venous ThromboembolismRakan Saadoun, David T Guerrero, Fuat Baris Bengur, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
International Journal of Molecular Sciences|February 15, 2022
Nanocarrier-Based Delivery of SN22 as a Tocopheryl Oxamate Prodrug Achieves Rapid Tumor Regression and Extends Survival in High-Risk Neuroblastoma ModelsIvan S Alferiev, David T Guerrero, Danielle Soberman, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 22, 2022
Poloxamer-linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high-risk neuroblastoma with primary and acquired chemoresistanceIvan S Alferiev, David T Guerrero, Peng Guan, et al.
Facial Plastic Surgery & Aesthetic Medicine|November 3, 2022
Comparison of Soluble and Liposome Encapsulated, Sustained Release Latanoprost for Focal Adipose ReductionShawn Loder, Joseph Sukinik, Matthew Cannon, et al.
Cancer Research|August 26, 2020
Structural Optimization and Enhanced Prodrug-Mediated Delivery Overcomes Camptothecin Resistance in High-Risk Solid TumorsFerro Nguyen, Peng Guan, David T Guerrero, et al.
JAMA Otolaryngology-- Head & Neck Surgery|December 5, 2024
Hypothermia During Microsurgical Head and Neck Reconstruction and Incidence of Venous ThromboembolismRakan Saadoun, David T Guerrero, Fuat Baris Bengur, et al.
Pageof 2